Web3 & Blockchain

Revelstoke Capital Partners is a Denver-based private equity firm focused on building industry-leading companies in the healthcare and related business services sectors. The firm partners with entrepreneurs and management teams to execute a disciplined organic and acquisition growth strategy, aiming to build exceptional companies. Since its inception in 2013, Revelstoke has raised over $2.3 billion in equity and completed 65 acquisitions, including 17 platform companies and 48 add-on acquisitions.

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Established in 1996, VantagePoint Capital Partners is a global venture investor with a focus on energy innovation and efficiency. With over $4 billion under management, the firm supports companies from start-up to scale-up, providing not only capital but also strategic resources, partnership alliances, and ongoing support. Headquartered in Silicon Valley, VantagePoint has offices in Beijing and strategic partners worldwide, emphasizing its commitment to energy innovation and efficiency.

Bering Capital is a venture capital firm with a passion for investing in extraordinary people and cutting-edge biotech and medical technology companies. The firm is dedicated to transforming groundbreaking ideas into world-class companies by leveraging its expertise in identifying critical problems and acting decisively. Bering Capital draws on lessons from early Silicon Valley pioneers and its own entrepreneurial ventures to shape the early DNA of companies for success. The firm believes in the primacy of great markets and great people, all aligned with one mission.

Serra Ventures, LLC is a venture capital firm that focuses on catalyzing innovation by funding early-stage tech startups across the United States. With a strong presence in Champaign, Chicago, San Diego, and Park City, Serra Ventures has funded over 100 early-stage tech startups, emphasizing its commitment to fostering growth and innovation in the tech industry.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

3E Bioventures Capital is a venture capital firm focused on life sciences, investing in global health innovators. The firm targets Biotech, including new drugs, modalities, and drug discovery platforms, as well as TechBio, which merges biology and technology to disrupt traditional paradigms. 3E Bioventures follows a science-driven, entrepreneur-friendly investment approach, collaborating with companies and research institutions to develop solutions for unmet medical needs. The firm's philosophy is encapsulated in its name, 3E: Expertise, Efficiency, Execution.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on advancing high potential new venture opportunities. It supports IU students, faculty, staff, and alumni in creating and growing startups that generate significant social and economic impact for Indiana University, the state of Indiana, and the world. The organization manages several investment programs, including the IU Philanthropic Venture Fund, IU Angel Network, and IU Founders & Funders Network, to foster a pervasive entrepreneurial culture and contribute to economic development.

Brain Trust Accelerator Fund is a venture capital firm focused on impact investing in brain-related diseases. The firm specializes in translational stage investments that address the diagnosis and treatment of these diseases. With a strong track record, Fund I has generated top-tier returns, benefiting up to ten million patients and delivering significant charitable contributions. The firm leverages scientific advancements and market opportunities to invest in early-stage, translational research, aiming to transform pioneering research into meaningful clinical benefits.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Camino Real Capital Partners, LLC (CRCP) is a private investment firm based in Santa Fe, New Mexico, dedicated to investing in America's leading innovators and emerging technologies. The firm emphasizes building relationships, fostering growth opportunities, and creating value. CRCP focuses on transformative technology, emerging medical devices, life science innovations, and cutting-edge service providers in the energy sector. The firm invests its own capital alongside a network of accredited co-venturers, providing technology and marketing insights and management guidance to early-stage innovators.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

NSG Ventures is a global biotech venture capital firm managed by founders and scientists. The firm is dedicated to investing in innovative solutions to tackle humanity's greatest challenges, particularly diseases. NSG Ventures partners with exceptional teams to push scientific boundaries and achieve medical breakthroughs.